company background image
538965 logo

Concord Drugs BSE:538965 Stock Report

Last Price

₹37.53

Market Cap

₹385.8m

7D

-1.2%

1Y

12.5%

Updated

08 Nov, 2024

Data

Company Financials

Concord Drugs Limited

BSE:538965 Stock Report

Market Cap: ₹385.8m

538965 Stock Overview

Engages in the manufacture and sale of pharmaceutical formulations in India.

538965 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance1/6
Financial Health2/6
Dividends0/6

Concord Drugs Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Concord Drugs
Historical stock prices
Current Share Price₹37.53
52 Week High₹61.50
52 Week Low₹30.59
Beta0.37
11 Month Change0.54%
3 Month Change7.54%
1 Year Change12.47%
33 Year Change20.29%
5 Year Change108.50%
Change since IPO87.74%

Recent News & Updates

Recent updates

Shareholder Returns

538965IN PharmaceuticalsIN Market
7D-1.2%-0.6%0.8%
1Y12.5%51.3%36.2%

Return vs Industry: 538965 underperformed the Indian Pharmaceuticals industry which returned 51.3% over the past year.

Return vs Market: 538965 underperformed the Indian Market which returned 36.2% over the past year.

Price Volatility

Is 538965's price volatile compared to industry and market?
538965 volatility
538965 Average Weekly Movement5.0%
Pharmaceuticals Industry Average Movement6.3%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.3%
10% least volatile stocks in IN Market4.0%

Stable Share Price: 538965 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 538965's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1995185Seelam Reddyconcorddrugs.in

Concord Drugs Limited engages in the manufacture and sale of pharmaceutical formulations in India. It offers tissue bio-adhesive products. The company also provides ready-to-fill pellets and multiple unit pellets system; drugs in the form of tablets, capsules, small volume parenterals, dry powders, syrups and suspension, and dry syrups; and hand sanitizers.

Concord Drugs Limited Fundamentals Summary

How do Concord Drugs's earnings and revenue compare to its market cap?
538965 fundamental statistics
Market cap₹385.80m
Earnings (TTM)₹92.00k
Revenue (TTM)₹476.36m

4,079x

P/E Ratio

0.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
538965 income statement (TTM)
Revenue₹476.36m
Cost of Revenue₹364.87m
Gross Profit₹111.49m
Other Expenses₹111.40m
Earnings₹92.00k

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.0092
Gross Margin23.41%
Net Profit Margin0.019%
Debt/Equity Ratio51.8%

How did 538965 perform over the long term?

See historical performance and comparison